c.i. 42510 has been researched along with Muscle Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, RJ; Corse, AM; Flanigan, KM; Porter, NC; Reed, PW | 1 |
| Masi, AT; Scherer, AT | 1 |
| McNamara, JJ; Segovia, E; Zeitlin, P | 1 |
3 other study(ies) available for c.i. 42510 and Muscle Disorders
| Article | Year |
|---|---|
Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.
Topics: Biopsy; Crystallins; Electrophoresis, Gel, Two-Dimensional; Humans; Immunoblotting; mu-Crystallins; Muscle, Skeletal; Muscular Diseases; Muscular Dystrophy, Facioscapulohumeral; Oxidative Stress; Rosaniline Dyes; Silver Staining; Up-Regulation | 2007 |
Technical aspects of the Haematoxylin--Basic Fuchsin--picric acid (HBFP) stain applied to skeletal muscle.
Topics: Hematoxylin; Histocytochemistry; Humans; Methods; Muscles; Muscular Diseases; Picrates; Rosaniline Dyes; Staining and Labeling; Time Factors | 1975 |
Critical evaluation of the hematoxylin-basic fuchsin picric acid stain as an indication of early muscle ischemia.
Topics: Animals; Evaluation Studies as Topic; Ischemia; Muscular Diseases; Picrates; Rats; Rosaniline Dyes; Staining and Labeling | 1974 |